Abstract
Transcatheter aortic valve implantation (TAVI or TAVR) was developed as an alternative to surgical aortic valve replacement (SAVR) for inoperable or high-risk patients. Originally, this method was intended for the treatment of patients with aortic stenosis. Currently, there are several types of valves implanted percutaneously. The periprocedural complications of TAVI are not frequent. Using the second-generation or third-generation valves, the results of TAVI are improving and therefore TAVI is currently recommended also for intermediate-risk patients. For several reasons, TAVI in patients with AR is still problematic and is a subject of clinical research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.
Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014;311:1503–14.
Wendler O, Schymik G, Treede H, et al. SOURCE 3 registry: design and 30-day results of the European postapproval registry of the latest generation of the SAPIEN 3 transcatheter heart valve. Circulation. 2017;135:1123–32.
Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–25.
Grube E, Van Mieghem NM, Bleiziffer S, et al. Clinical outcomes with a repositionable self-expanding transcatheter aortic valve prosthesis: the International FORWARD Study. J Am Coll Cardiol. 2017;70:845–53.
Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J. 2003;24:1231–43.
D’Ancona G, Pasic M, Buz S, et al. TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device. Ann Thorac Surg. 2012;93:e89–91.
Roy DA, Schaefer U, Guetta V, et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol. 2013;61:1577–84.
Testa L, Latib A, Rossi ML, et al. CoreValve implantation for severe aortic regurgitation: a multicentre registry. EuroIntervention. 2014;10:739–45.
Seiffert M, Diemert P, Koschyk D, et al. Transapical implantation of a second-generation transcatheter heart valve in patients with noncalcified aortic regurgitation. JACC Cardiovasc Interv. 2013;6:590–7.
Seiffert M, Bader R, Kappert U, et al. Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation. JACC Cardiovasc Interv. 2014;7:1168–74.
Babaliaros V, Cribier A. The expansion of transcatheter technology to treat aortic insufficiency: everything old becomes new again. JACC Cardiovasc Interv. 2014;7:1175–6.
Barbanti M, Ye J, Pasupati S, et al. The Helio transcatheter aortic dock for patients with aortic regurgitation. EuroIntervention. 2013;9(Suppl):S91–4.
Pasupati S, Devlin G, Davis M, et al. Transcatheter solution for pure aortic insufficiency. JACC Cardiovasc Imaging. 2014;7:315–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Brtko, M. (2018). Transcatheter Aortic Valve Implantation (TAVI). In: Vojacek, J., Zacek, P., Dominik, J. (eds) Aortic Regurgitation. Springer, Cham. https://doi.org/10.1007/978-3-319-74213-7_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-74213-7_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74212-0
Online ISBN: 978-3-319-74213-7
eBook Packages: MedicineMedicine (R0)